XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2022
Cash Flows from Operating Activities      
Net increase (decrease) in net assets resulting from operations $ (4,092,470) $ 3,234,503 $ 2,586,630
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:      
Origination and purchase of investments (62,524,462) (51,269,621) (144,746,910)
Payment in-kind interest and dividends (2,870,741) (1,968,260) (633,752)
Sales and repayments of investments 92,303,435 61,928,745 153,877,788
Net realized (gain) loss on investments 13,971,537 26,890,095 14,395,431
Net change in unrealized appreciation/depreciation on investments (3,287,977) (20,696,532) (8,058,117)
Amortization of discount/premium on investments (2,049,993) (1,311,770) (2,662,806)
Amortization of deferred debt issuance costs 576,474 693,333 621,111
Amortization of original issue discount 71,110 71,110 71,110
Net (increase) decrease in operating assets:      
Interest receivable 740,361 256,566 203,148
Payment-in-kind interest receivable (20,537) (43,951) 39,610
Principal receivable 42,972 741,462 5,040,250
Long-term receivable (631,667) 0 0
Escrow receivable (97,173) 0 0
Other receivables 1,050 (1,050) 427,208
Prepaid expenses and other assets (50,102) 48,682 (34,204)
Net increase (decrease) in operating liabilities:      
Payable for investments purchased 5,629,703 1,548,313 246,984
Interest payable (342,841) 719,410 624,996
Directors fees payable (15,755) (5,025) (8,079)
Accrued expenses and other liabilities 240,189 (375,015) (294,737)
Base management fees payable (89,441) (147,845) (16,517)
Income-based incentive fees payable (447,147) 393,928 (465,790)
Net cash (used in) provided by operating activities 37,056,525 20,707,078 21,213,354
Cash Flows from Financing Activities:      
Payments for deferred financing costs (1,010,788) 0 (1,300,000)
Issuance of common shares 0 0 3,141,576
Distributions to stockholders (11,188,149) (8,610,939) (8,505,056)
Repayments of Term loan 0 0 (102,000,000)
Proceeds from borrowing on revolving financing facility 37,100,000 46,900,000 182,835,346
Repayments of borrowing on revolving financing facility (66,000,000) (59,000,000) (98,835,346)
Net cash (used in) provided by financing activities (41,098,937) (20,710,939) (24,663,480)
Net change in cash (4,042,412) (3,861) (3,450,126)
Cash:      
Cash and restricted cash at beginning of year [1] 9,151,216 [2] 9,155,077 [2] 12,605,203
Cash and restricted cash at end of period [2] 5,108,804 9,151,216 [1] 9,155,077 [1]
Supplemental and non-cash financing cash flow information:      
Cash paid for interest 8,949,150 7,693,998 6,008,590
Cash paid for taxes 267,150 294,330 270,618
Issuance of shares pursuant to Dividend Reinvestment Plan 40,213 21,749 56,093
Non-cash purchase of investments (37,002,608) (16,865,488) (2,903,400)
Non-cash sale of investments $ 37,002,608 $ 16,865,488 $ 2,903,400
[1] Represents $1,093,758, $2,550,021 and $5,845,249 of unrestricted cash as of June 30, 2024, June 30, 2023 and June 30, 2022, respectively, and $8,057,458, $6,605,056 and $6,759,954 of restricted cash for the same periods.
[2] Represents $158,768, $1,093,758 and $2,550,021 of unrestricted cash as of June 30, 2024, June 30, 2023 and June 30, 2022, respectively, and $4,950,036, $8,057,457 and $6,605,056 of restricted cash for the same periods.